TY - JOUR
T1 - High versus low chloride load in adult hyperglycemic emergencies with acute kidney injury
T2 - a multicenter retrospective cohort study
AU - Takahashi, Kyosuke
AU - Uenishi, Norimichi
AU - Sanui, Masamitsu
AU - Uchino, Shigehiko
AU - Yonezawa, Naoki
AU - Takei, Tetsuhiro
AU - Nishioka, Norihiro
AU - Kobayashi, Hirotada
AU - Otaka, Shunichi
AU - Yamamoto, Kotaro
AU - Yasuda, Hideto
AU - Kosaka, Shintaro
AU - Tokunaga, Hidehiko
AU - Fujiwara, Naoki
AU - Kondo, Takashiro
AU - Ishida, Tomoki
AU - Komatsu, Takayuki
AU - Endo, Koji
AU - Moriyama, Taiki
AU - Oyasu, Takayoshi
AU - Hayakawa, Mineji
AU - Hoshino, Atsumi
AU - Matsuyama, Tasuku
AU - Miyamoto, Yuki
AU - Yanagisawa, Akihiro
AU - Wakabayashi, Tadamasa
AU - Ueda, Takeshi
AU - Komuro, Tetsuya
AU - Sugimoto, Toshiro
AU - Sasabuchi, Yusuke
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI) 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Hyperglycemic emergencies frequently lead to acute kidney injury (AKI) and require treatment with large amount of intravenous fluids. However, the effects of chloride loading on this population have not yet been investigated. We conducted a multicenter, retrospective, cohort study in 21 acute-care hospitals in Japan. The study included hospitalized adult patients with diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) who had AKI upon arrival. The patients were classified into high and low chloride groups based on the amount of chloride administered within the first 48 h of their arrival. The primary outcome was recovery from AKI; secondary outcome was major adverse kidney events within 30 days (MAKE30), including mortality and prolonged renal failure. A total of 390 patients with AKI, including 268 (69%) with DKA and 122 (31%) with HHS, were included in the study. Using the criteria of Kidney Disease Improving Global Outcomes, the severity of AKI in the patients was Stage 1 (n = 159, 41%), Stage 2 (n = 121, 31%), and Stage 3 (n = 110, 28%). The analysis showed no significant difference between the two groups in recovery from AKI (adjusted hazard ratio, 0.96; 95% CI 0.72–1.28; P = 0.78) and in MAKE30 (adjusted odds ratio, 0.91; 95% CI 0.45–1.76; P = 0.80). Chloride loading with fluid administration had no significant impact on recovery from AKI in patients with hyperglycemic emergencies. Trial Registration This study was registered in the UMIN clinical trial registration system (UMIN000025393, registered December 23, 2016).
AB - Hyperglycemic emergencies frequently lead to acute kidney injury (AKI) and require treatment with large amount of intravenous fluids. However, the effects of chloride loading on this population have not yet been investigated. We conducted a multicenter, retrospective, cohort study in 21 acute-care hospitals in Japan. The study included hospitalized adult patients with diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) who had AKI upon arrival. The patients were classified into high and low chloride groups based on the amount of chloride administered within the first 48 h of their arrival. The primary outcome was recovery from AKI; secondary outcome was major adverse kidney events within 30 days (MAKE30), including mortality and prolonged renal failure. A total of 390 patients with AKI, including 268 (69%) with DKA and 122 (31%) with HHS, were included in the study. Using the criteria of Kidney Disease Improving Global Outcomes, the severity of AKI in the patients was Stage 1 (n = 159, 41%), Stage 2 (n = 121, 31%), and Stage 3 (n = 110, 28%). The analysis showed no significant difference between the two groups in recovery from AKI (adjusted hazard ratio, 0.96; 95% CI 0.72–1.28; P = 0.78) and in MAKE30 (adjusted odds ratio, 0.91; 95% CI 0.45–1.76; P = 0.80). Chloride loading with fluid administration had no significant impact on recovery from AKI in patients with hyperglycemic emergencies. Trial Registration This study was registered in the UMIN clinical trial registration system (UMIN000025393, registered December 23, 2016).
UR - http://www.scopus.com/inward/record.url?scp=85187878297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85187878297&partnerID=8YFLogxK
U2 - 10.1007/s11739-024-03556-0
DO - 10.1007/s11739-024-03556-0
M3 - Article
C2 - 38488997
AN - SCOPUS:85187878297
SN - 1828-0447
VL - 19
SP - 959
EP - 970
JO - Internal and Emergency Medicine
JF - Internal and Emergency Medicine
IS - 4
ER -